News
The latest GID BIO and cellular therapy news.
Former Yahoo! Chairman, Wall Street Titan Roy J. Bostock Joins GID BIO as Chair
LOUISVILLE, Colo., July 28, 2020 -- Roy J. Bostock, former Chairman of Yahoo!, Vice Chairman of Delta Airlines and a director of Morgan Stanley, has joined the cellular medicine startup GID BIO...
- GID BIO News
- July 28, 2020
- News
GID BIO reaches halfway enrollment in randomized double-blinded pivotal Phase III cell therapy trial
GID BIO reaches halfway enrollment in randomized double-blinded pivotal Phase III cell therapy trial
FDA-compliant trial addresses treatment gap for regenerative medicine to potentially treat knee osteoarthritis...
- GID BIO News
- April 6, 2023
- News
GID BIO welcomes director of clinical operations
We tapped Sandeep Samudre, PhD, MPH, to lead our trial operations including the pivotal trial for knee osteoarthritis and other efforts in our pipeline across...
- GID BIO News
- August 15, 2022
- News
Dr. Manish Gupta joins the GIDOA-3 team
Dr. Manish Gupta, an orthopaedic surgeon with a sports medicine focus enters as GID BIO’s newest principal investigator in a pivotal trial of the GID SVF-2...
- GID BIO News
- May 17, 2022
- News
The FDA approval process is important for patient safety and cell therapy research
In 2017, the Food and Drug Administration gave for-profit stem cell clinics three years to engage the regulatory approval process to establish the safety...
- GID BIO News
- December 23, 2021
- Blog
FDA announces consolidation of regulatory oversight responsibilities for fat transfer devices that process adipose tissue for return to the body
The proper surveillance of medical devices is necessary to ensure the health and safety of the public, and the Food and Drug Administration is committed...
- GID BIO News
- December 10, 2021
- Blog